Nicholas Buss
Interventional Cardiology · Bend, ORNPI 1346414752
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $5,091 of the $6,773 with a category attached, or 75.2%. 10 manufacturers reported payments, led by Medtronic at 49.6% of the total. Reporting peaked in 2024 at $3,503 and has fallen 99.6% since, to $14 in 2025.
Across 56 payments — averaging $120.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Boston Scientific$1K
- Abbott$1K
- Abiomed$611
- Philips North America LLC$84
- Shockwave Medical, Inc$50
- plus $99 from 4 others
Across 24 payments — averaging $667.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$16K
What the payments were for
- Travel & lodging$5,09175%
- Food & beverage$1,68225%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 20 | $3,358 |
| Boston Scientific | 12 | $1,384 |
| Abbott | 8 | $1,188 |
| Abiomed | 7 | $611 |
| Philips North America LLC | 1 | $84 |
| Shockwave Medical, Inc | 3 | $50 |
| Amgen | 2 | $40 |
| Teleflex LLC | 1 | $26 |
| Getinge USA Sales, LLC | 1 | $18 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADVISA DR MRI SURESCAN$1,765
- GENERAL VASCULAR ACCESS$1,183
- OPTIS$874
- Impella$368
How this compares
$6,773 in reported general payments places this provider in the 60th percentile of 68 interventional cardiology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 89 | $116,383 |
| Repatha SureclickEvolocumab | 52 | $45,080 |
| JardianceEmpagliflozin | 46 | $42,824 |
| EntrestoSacubitril/Valsartan | 21 | $33,360 |
| XareltoRivaroxaban | 17 | $19,449 |
| Praluent PenAlirocumab | 11 | $7,043 |
| Metoprolol Succinate | 301 | $5,708 |
| Rosuvastatin Calcium | 122 | $4,036 |
| Ezetimibe | 68 | $2,865 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 67 | $2,412 |
| Losartan Potassium | 103 | $2,209 |
| Atorvastatin Calcium | 124 | $1,940 |
| Flecainide Acetate | 20 | $1,794 |
| Amiodarone Hcl | 61 | $1,415 |
| Carvedilol | 78 | $1,376 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $14 | $116,38389 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 68 interventional cardiology providers in Oregon.
Other interventional cardiology in Bend
- Saurabh GuptaBend$550K
- Erinn HughesBend$14K
- Alexander OchmanBend$6K
- Michael SultanBend$5K
- Bruce McLellanBend$4K
- Allen RafaelBend$3K
- Michael WidmerBend$2K
- Jason WollmuthPortland$749K
- Ethan KorngoldPortland$407K
- Amish DesaiPortland$186K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.